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874-2 Arginlne-Va$0pressin Is Beneficial In Weaning Children 
From Cardlopulmonary Bypass Following Open Heart 
Surgery 
~ena S. Abraham. Edka Berman-Rosenzweig, Howard A. Zucker, Arthur J. Smerling, 
Jan M. Quaegebeur, Thomas J. Starc, Cd//ege of Physicians and Surgeons, Columbia 
University, New York, New York. 
Background: A relative arginine-vasoprassin (AVP) deficiency state has been described 
as a potential cause of vasodilatory shock following cardiopulmonary bypass (CPB) in 
adults and children. Although there is considerable experience using low dose AVP in 
adults with vasodilatory shock coming off CPB, data on the use of AVP in children is lim- 
ited. The purpose of this report is to describe the intraoperative use of low dose AVP dur- 
ing attempts to wean children from CPB after open-heart surgery. 
Methods: We reviewed the records of 10 children (median age 2 months, range 3 days 
to 15 years) who received AVP for blood pressure (BP) support dudng weaning from 
CPB, following repair of congenital heart disease (n=9) or cardiac transplantation (n=l). 
Before treatment with AVP, children received multiple pressors and inotropes including 
dopamine (n=l), dobutamine (n=8), epinephdne (n=7) and milrinone (n=5). AVP was 
used during the initial attempt o wean from CPB in 4, after an unsuccessful attempt in 5 
and after two unsuccessful attempts in 1. Median dose of AVP was 0.004 units/kg/min 
and ranged from 0.0006 to 0.01 units/kg/min. 
Results: After 15-30 minutes of AVP, mean arterial BP increased from 36 ± 10 to 57 ± 
12mmHg (p<0.0001; paired t test; n=10). Systolic BP increased from 50 + 14 to 82 + 
17mmHg (p<0.001; n=6) and diastolic BP increased from 29 + 10 to 43 ± 14mmHg 
(p<0.05; n=6). Eight children were successfully weaned off CPB with concomitant dse in 
systolic BP. Two children went on to extra corporeal membrane oxygenation despite an 
initial rise in systolic BP with AVP. Eight children were successfully weaned off AVP and 
survived the perioperative pedod. Seven of these children were discharged from the hos- 
pital and one died 5 months following surgery. Two patients died 5 hours after CPB sec- 
ondary to cardiogenic shock, despite treatment with AVP. 
Conclusion: Low close AVP is associated with an increase in BP in patients following 
CPB. Our data suggest that AVP may be beneficial in infants and children with hypoten- 
sion secondary to vasodilatory shock who are unable to be weaned from CPB with con- 
ventional therapy. Further studies to identify ideal candidates for AVP therapy following 
CPB are warranted. 
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874-3 Gtucocorticold Pretreatment for  Congenital Heart 
Surgery Improves Cardiac Output and Reduces Bypass 
Induced Cytoklne and Adhesion Molecule Expression 
Valerie A. Schroedar, Jeffery M. Pearl, Peter B. Manning, Thomas P. Shanley, David P. 
Nelson, Children's Hospital Medical Center, Cincinnati, Ohio. 
Background: Steroid treatment before cardiopulmonary bypass (CPB) is thought to 
improve cardiopulmonary function by modulating CPB induced inflammation. We per- 
formed a randomized, blinded, placebo-controlled clinical trial to assess efficacy of ste- 
roid pretreatment on postoperative outcome and CPB induced inflammation. 
Methods: 35 patients (age 2 d-6 y) undergoing CPB for congenital heart surgery (10- 
TGV, 10-TOF, 3-ASD, 3-HLHS, 7-AV canal defects) were randomized to receive 30mg/kg 
Methylprednisolone (MP, n=16) or placebo (n=19) 4h before CPB. All patients received 
intraoperative MP (30mg/kg). Myocardial cytokine and adhesion molecule expression 
was determined in paired atrial biopsies (pro and end-CPB) by ribonuclease protection. 
Serum IL-6 and IL-10 levels were measured pre-and post-CPB by ELISA. Postoperative 
outcome was assessed by arteriovenous 02 difference (DAV02), inotrope use, serum 
lactate and troponin I levels, PaO2/FiO2 ratio, intubation time and ICU duration. 
Results: MP pretreatment resulted in lower cardiac mRNA expression of cytokines (IL-6, 
IL-10, MCP-1 and RANTES, p<0.05), and adhesion molecules ( ICAM -1 and E-se[ectin, 
p<0.05)) at end-CPB. MP-pretreatment reduced serum IL-6 levels and increased IL-10 
levels at end-CPB and 4h post-CPB (p<0.05). By 24 h post-CPB, serum IL-6 was 
equally elevated in both groups, and IL-10 had normalized. MP-pretroated patients had 
reduced DAVO2a between 12-20h post-CPB (p<0.05), but this was not associated with 
differences in other clinical outcomes. All patients survived to discharge. 
Conclusion: Reduced expression of cardiac proinflammatory mediators in MP-pre- 
treated patients corresponded to improved indices of cardiac output at a time when it is 
typically lowest, but there were no differences in other outcome measures, Furthermore, 
since the effects of preoperative MP appear to be transient, additional steroid treatment 
postoperatively may further enhance anti-inflammatory effects. 
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874-4 Glucocort icolds Reduce Troponin I Degradation in a 
Neonatal Piglet Model of Cardlopulmonary Bypass 
Staven M. Schwartz. Jodie Y. Dully, David P. Nelson, Semin Goins, Robert Ferguson, 
Jeffrey M. Pearl, Children's Hospital Medical Center, Cincinnati, Ohio. 
Degradation of troponin I (Tnl) by the calcium activated protease calpatn is a cause of 
myocardial stunning due to ischemia/raperfusion i jury. Glucocorticoids (GC) attenuate 
myocardial ischemia/raporfusion i jury but their effect on Tnl degradation is unknown. 
We used a neonatal piglet model of cardiopulmonary bypass (CPB) to test the hypothe- 
ses that 1. CPB is associated with Tnl degradation in the neonatal heart and 2. Preoper- 
ative GC are associated with a decrease in CPB-mediated Tnl degradation and improved 
left ventdcular (LV) function. METHODS: Neonatal piglets were cooled to 18 ° C on CPB 
and subjected to 2 hours of circulatory arrest. Animals were rewarmed to 37 ° and allowed 
to recover for 2 hours. Methylprednieolone was administered 6 hours before surgery 
(30mg/kg) and at initation of CPB (30 mg/kg). The control group received saline. LV tis- 
sue was collected at the end of recovery and tissue analyzed by chemiluminescent west- 
ern blot for Tnl, calpain and the peptide inhibitor of calpain, calpastatin. RESULTS: Tnl 
degradation products were detected in LV myocardium after CPB, cold ischemic arrest 
and reperfusion. In addition to intact Tnl at 29 kDa, selective degradation products of 22, 
18, and 15 kDA were identified. Administration of GC was associated with alteration in 
the pattern of Tnl degradation products with increased preservation of intact Tnl and a 
decrease in the 22 kDa degradation product. Although the 80 kDa catalytic subunit of 
calpain I was increased to 111%+16 of controls (p<0.05), calpastatin levels were 
increased to 128%+7 of control levels (p<0.05). Mean LV +dP/dt decreased to 68%_+15 
of baseline in control animals by 2 hours of recovery, but was maintained at 92%+12 
(p<0.05) of baseline in the GC group. CONCLUSIONS: Tnl degradation may be an 
important cause of myocardial dysfunction following CPB in neonates. Reduction in rep- 
ertusion injury by GC may be partly dependent on increases in calpastatin activity and/or 
subsequent preservation of intact Tnl. 
